Home / Biopharma (page 10)

Biopharma

Peregrine Pharmaceuticals (NASDAQ:PPHM)- Short Call on Analysts Review: Global Blood Therapeutics (NASDAQ:GBT)

Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) [Trend Analysis] attempts to attain leading position in street, Shares price changes as it -0.42% to close at $0.36 with the total traded volume of 3.76 Million shares. Peregrine Pharmaceuticals, Inc. (PPHM) reported the publication of positive proof-of-concept data for a novel exosome-based cancer detection platform.  …

Read More »

Protalix BioTherapeutics (NYSE:PLX)- Profitability Ratios Proving Vital for Investment: Intercept Pharmaceuticals (NASDAQ:ICPT)

Protalix BioTherapeutics, Inc. (NYSE:PLX) kept active in profitability ratio analysis, on current situation shares price rose 9.68% to $1.02. The total volume of 4.87 Million shares held in the session, while on average its shares change hands 2981.80 shares. Protalix BioTherapeutics, Inc. (PLX) reported that a review of the Company’s …

Read More »

Teva Pharmaceutical Industries (NYSE:TEVA)- Critical Profitability Ratio Analysis: Eli Lilly and Company (NYSE:LLY)

Teva Pharmaceutical Industries Limited (NYSE:TEVA) kept active in profitability ratio analysis, on current situation shares price knocked up 0.31% to $32.35. The total volume of 6.67 Million shares held in the session, while on average its shares change hands 10446.24 shares. Efficiency Evaluation in Focus Entering into profitability analysis, the …

Read More »